ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,520.25
0.17%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Madrigal Pharmaceuticals Inc (MDGL)

  7. Madrigal Pharmaceuticals Inc (MDGL) Noticias

MDGL Madrigal Pharmaceuticals Inc

193.00
-1.38 (-0.71%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Madrigal Pharmaceuticals Inc MDGL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-1.38 -0.71% 193.00 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
192.49 189.00 195.58 193.33 194.38
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
23/4/202407:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
16/4/202415:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
09/4/202407:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
03/4/202415:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/3/202422:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
18/3/202415:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
15/3/202406:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
14/3/202415:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
06/3/202415:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
05/3/202407:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
28/2/202406:10EDGAR2Form 8-K - Current report
28/2/202406:01EDGAR2Form 8-K - Current report
28/2/202406:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
28/2/202406:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
28/2/202405:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202407:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
14/2/202413:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202416:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202407:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
06/2/202415:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
29/1/202407:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
25/1/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202414:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202414:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202414:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202407:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/1/202412:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202412:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202412:45EDGAR2Form 8-K - Current report
04/1/202407:00GLOBEMadrigal Pharmaceuticals Presents Five Health Economics..
03/1/202415:30GLOBEMadrigal Pharmaceuticals to Present at the 42nd Annual J.P...
22/12/202315:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
06/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202315:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
22/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202316:24EDGAR2Form SC 13D/A - General statement of acquisition of..
21/11/202307:00GLOBEMadrigal Pharmaceuticals Appoints Ronald Filippo as Chief..
15/11/202315:45GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..

Su Consulta Reciente

NASDAQ
MDGL
Madrigal Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados